DI
JAZZ icon

Disciplined Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Disciplined Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9
Closed -$1.12K – 830
2023
Q2 		$1.12K Buy
9
+1
+13% +$135 ﹤0.01% 920
2023
Q1 		$1.17K Sell
8
-3
-27% -$444 ﹤0.01% 891
2022
Q4 		$1.75K Buy
11
+3
+38% +$440 ﹤0.01% 672
2022
Q3 		$1K Sell
8
-3
-27% -$456 ﹤0.01% 956
2022
Q2 		$2K Buy
11
+1
+10% +$154 ﹤0.01% 673
2022
Q1 		$2K Buy
+10
New +$1.45K ﹤0.01% 716

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Disciplined Investments's JAZZ Position: Q3 2023 in Review

Disciplined Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2023, closing a stake of 9 shares — an estimated $1.12K sold.

Disciplined Investments first reported a position in JAZZ in Q1 2022 and held it in 6 quarters. The position peaked at $2K in Q2 2022. 484 funds tracked by Wall St. Rank hold JAZZ as of Q3 2023.

  • Disciplined Investments reported no remaining Jazz Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 9 Jazz Pharmaceuticals shares in Q3 2023, an estimated $1.12K.
  • Disciplined Investments first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Jazz Pharmaceuticals position peaked at $2K in Q2 2022.
  • 484 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.